Transcept Pharmaceuticals Inc·4

Jan 8, 7:05 PM ET

Singh Nikhilesh N 4

4 · Transcept Pharmaceuticals Inc · Filed Jan 8, 2013

Insider Transaction Report

Form 4
Period: 2013-01-07
Singh Nikhilesh N
SVP & Chief Scientific Officer
Transactions
  • Award

    Common Stock Option (right to buy)

    2013-01-07+120,000120,000 total
    Exercise: $5.40Exp: 2023-01-07Common Stock (120,000 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    295
  • Common Stock

    (indirect: See footnote)
    78,206
  • Common Stock

    2,699
Footnotes (4)
  • [F1]This total includes 1,145 shares purchased on November 30, 2012 under the 2009 Employee Stock Purchase Plan.
  • [F2]Shares held directly by the Reporting Person's spouse.
  • [F3]Shares held directly by the Singh Family Trust (the "Family Trust") for which Reporting Person's spouse serves as trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Family Trust except to the extent of his pecuniary interest therein.
  • [F4]The option vests in forty-eight equal monthly installments beginning on February 7, 2013.

Documents

2 files